Efudex Related Clinical Trials
Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors [Active, not recruiting]
The Effect of Efudex Treatment on Photoaged Skin [Completed]
Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal Carcinoma [Active, not recruiting]
A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women [Completed]
Phase II Study of Oxaliplatin in Combination With 5-Fu in 1st Line Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and Neck [Completed]
XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors [Terminated]
Definitive Chemoradiation With Gemcitabine and Continuous Fluorouracil (5- FU) Followed by High Dose Rate Brachytherapy or Stereotactic Body Radiation Therapy Boost in Locally Advanced Intra or Extrahepatic Cholangiocarcinoma [Recruiting]
A Dose Escalation Study of MK1775 in Combination With 5-FU or 5-FU/CDDP in Patients With Advanced Solid Tumor (1775-005) [Recruiting]
Combination of Brivanib With 5-Fluorouracil/Leucovorin (5FU/LV) and 5-Fluorouracil/Leucovorin/Irinotecan (FOLFIRI) [Recruiting]
Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer. [Active, not recruiting]
Pre-operative 5-Fluorouracil (5-FU) and Sorafenib With External Radiation in Locally Advanced Rectal Cancer [Recruiting]
Study of MM-398 With or Without 5-Fluorouracil and Leucovorin, Versus 5-Fluorouracil and Leucovorin in Patients With Metastatic Pancreatic Cancer [Recruiting]
Hepatic Arterial Infusion Oxaliplatin + 5FU, Leucovorin, and Bevacizumab +/- Cetuximab [Recruiting]
Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based Chemotherapy [Recruiting]
Pralatrexate and Fluorouracil in Treating Patients With Recurrent Solid Tumors [Recruiting]
Trametinib, Fluorouracil, and Radiation Therapy Before Surgery in Treating Patients With Stage II-III Rectal Cancer [Recruiting]
A Study of 5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal Metastasis [Active, not recruiting]
Neoadjuvant FOLFOX6 Chemotherapy With or Without Radiation in Rectal Cancer [Recruiting]
Safety Study of Oxaliplatin and 5-fluorouracil Followed by FUDR for Unresectable Colorectal Liver Metastases [Recruiting]
Cetuximab, 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer [Recruiting]
Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX) [Recruiting]
5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer [Recruiting]
Induction Therapy-Docetaxel, Cisplatin and Fluorouracil in Untreated Advanced Squamous Cell or Undifferentiated Carcinoma of the Paranasal Sinuses [Recruiting]
Intra-operative Chemotherapy With 5-FU for Colorectal Cancer Patients Receiving Curative Resection: Efficacy and Safety [Recruiting]
Randomized Multicenter Study Comparing Docetaxel Plus Cisplatin and 5-FU to Cisplatin Plus 5-FU in Advanced Gastric Cancer [Completed]
Everolimus, Fluorouracil, Leucovorin, Panitumumab, and Oxaliplatin in Treating Patients With Solid Tumors That Did Not Respond to Treatment [Recruiting]
Paclitaxel, Carboplatin and Cetuximab (PCC) Versus Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) [Recruiting]
Simultaneous Integrated Boost (SIB) in Esophageal Cancer [Recruiting]
Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer [Recruiting]
Efficacy Study of Neoadjuvant Chemotherapy With Chemoradiation Therapy for Nasopharyngeal Carcinoma [Recruiting]
PD-0332991, 5-FU, and Oxaliplatin for Advanced Colorectal Cancer [Recruiting]
Study to Evaluate the Safety and Tolerability of BMS-906024 in Combination With Chemotherapy (Weekly Paclitaxel, 5FU Plus Irinotecan (FOLFIRI) or Carboplatin Plus Paclitaxel) in Subjects With Advanced or Metastatic Solid Tumors [Recruiting]
Uridine Triacetate as an Antidote for Patients at Excess Risk of 5-Fluorouracil (5-FU) Toxicity Due to Overdosage or Impaired Elimination [Available]
Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies [Active, not recruiting]
Comparison of Subconjunctival 5-Fluorouracil (FU) Injection and Mitomycin C for Treatment of Early Bleb Failure [Recruiting]
Intraoperative Chemotherapy Against Hepatocellular Carcinoma Recurrence [Recruiting]
Fluorouracil and Leucovorin and/or Levamisole After Surgery In Treating Patients With Dukes' B Or Dukes' C Colon Cancer [Active, not recruiting]
Vorinostat in Combination With Radiation Therapy and Infusional Fluorouracil (5-FU) in Patients With Locally Advanced Adenocarcinoma of the Pancreas [Recruiting]
Phase I Trial of huA33 Plus Chemotherapy in Patients With Metastatic Colorectal Cancer [Active, not recruiting]
Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma [Recruiting]
Study Comparing Optimized 5-FU Dosing and Standard Dosing in Metastatic Colorectal Cancer Patients Treated With mFOLFOX6 [Recruiting]
Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic Crc [Recruiting]
Endometrial Cancer - LOHP Alone and With 5FU [Completed]
DAVANAT Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer [Active, not recruiting]
Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal Cancer [Recruiting]
Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination [Active, not recruiting]
Safety of DAVANAT With and Without 5-Fluorouracil in Patients With Solid Tumors [Completed]
Skin Cancer Prevention [Recruiting]
High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon Cancer [Active, not recruiting]
Comparison of Adjuvant Chemotherapy Regimens in Treating Patients With Stage II or Stage III Rectal Cancer Who Are Receiving Radiation Therapy and Fluorouracil Before or After Surgery [Active, not recruiting]
Cetuximab Combined With Irinotecan in First-Line Therapy for Metastatic Colorectal Cancer (CRYSTAL) [Active, not recruiting]
Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancer [Recruiting]
Gemcitabine, Infusional 5 Fluorouracil and Bevacizumab in Patients With Advanced Pancreas Cancer [Recruiting]
Folfox-B Study for Patients With Colorectal Liver Metastases [Active, not recruiting]
Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck [Completed]
Measuring Adherence To Topical 5-Fluorouracil in a Clinic Population [Active, not recruiting]
Comparing Irinotecan and 5 FU/FA To 5-FU/FA After Resection Of Liver Metastases For Colorectal Cancer [Recruiting]
Induction Chemotherapy Comparing TaxotereŽ Cisplatin and 5-Fluorouracil (TPF) With Standard Cisplatin and 5-Fluorouracil (PF) Followed by Chemoradiation in Locally Advanced Head and Neck Cancer [Completed]
A Phase II Study of Oxaliplatin in Association With 5FU and Folinic Acid in the Treatment of Subjects With Non-Surgical or Advanced Metastatic Gastric Cancer [Completed]
Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck [Completed]
Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus [Completed]
A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly Intraperitoneal 5FU With Systemic Oxaliplatin/5FU/Leucovorin in Patients With Pseudomyxoma Peritonei or Peritoneal Carcinomatosis
5FU vs 5FU With Viscoelastic Formulation for the Prevention of Scarring Post-Trabeculectomy [Not yet recruiting]
A Randomized Trial of Avastin + Gemcitabine + 5FU/Folinic Acid vs Avastin + Oxaliplatin + 5FU/Folinic Acid in Metastatic Colorectal Cancer [Completed]
Phase I Study of PN401, Fluorouracil, Leucovorin and CPT-11 in Patients With Solid Tumors [Terminated]
Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer [Terminated]
Cetuximab (Erbitux) in Combination With Cisplatin or Carboplatin and 5-Fluorouracil in the First Line Treatment of Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (EXTREME)
Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon Cancer [Active, not recruiting]
Fluorouracil Plus Ethynyluracil in Treating Patients With Advanced Colorectal Cancer That Has Not Responded to Fluorouracil [Active, not recruiting]
Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction Patients [Recruiting]
Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy With 5-Fluorouracil and Oxaliplatin Versus 5-Fluorouracil Alone in Rectal Cancer [Recruiting]
Outcomes of Intraoperative 5-Fluorouracil Versus Mitomycin C [Completed]
Phase I/II CT 2106 and 5-FU/FA in Colorectal Cancer [Active, not recruiting]
A Study of 5 Fluorouracil and the Anti-Tumor Activity of ADH300004 and 5 Fluorouracil in Subjects With Incurable Solid Tumors [Recruiting]
Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer [Active, not recruiting]
Low-Dose CDGP/5-FU Combined With Radiation for Esophageal Cancer [Recruiting]
Using Positron Emission Tomography to Evaluate the Effects of Bevacizumab on Intra-Tumoral Pharmacokinetics of 5-Fluorouracil in Metastatic Colorectal Cancer [Completed]
Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal Adenocarcinoma [Recruiting]
Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer [Active, not recruiting]
Fluorouracil and Leucovorin Plus Either Irinotecan or Oxaliplatin With or Without Cetuximab in Treating Patients With Previously Untreated Metastatic Adenocarcinoma of the Colon or Rectum [Active, not recruiting]
Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to 5-Fluorouracil Based Chemotherapy in Stage III Colon Cancer [Active, not recruiting]
Randomized Phase 2 Trial of Pre-Chemotherapy Leukine Vs. Leukine-Dexamethasone in Combination With Gemzar & 5-FU in Patients With Metastatic Renal Cell Carcinoma [Withdrawn]
Safety and Efficacy Study of XELOX Vs. Oxaliplatin+5-FU CI as First Line Treatment in Metastatic Colorectal Cancer [Completed]
Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer [Active, not recruiting]
Phase II Study of Sorafenib and Infusional 5-Fluorouracil in Advanced Hepatocellular Carcinoma (HCC) [Recruiting]
Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients Following Surgery for Stage III Colorectal Cancer [Active, not recruiting]
Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer [No longer recruiting]
Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas
Docetaxel, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic or Unresectable Stomach Cancer, Gastroesophageal Junction Cancer, or Other Solid Tumor [Recruiting]
Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer [No longer recruiting]
Study of IMC-1121B in Combination With 5-FU/FA and Oxaliplatin Chemotherapies in Patients With Colorectal Cancer [Recruiting]
Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast Cancer [Recruiting]
FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal Cancer [Recruiting]
5FU/VL Vs LV5FU2 + CPT11 in Stage II-III Resected Rectal Cancer [Recruiting]
Fluorouracil With or Without Mitomycin in Treating Patients With Peritoneal Cancer [No longer recruiting]
5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage I/II Rectal Cancer [Recruiting]
Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric Patients [Recruiting]
Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors [Recruiting]
Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal Cancer [No longer recruiting]
Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility Project [Recruiting]
Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, Leucovorin, and Avastin [Recruiting]
|
